Haemonetics
316 hedge funds and large institutions have $4.62B invested in Haemonetics in 2024 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 113 increasing their positions, 106 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
6% more capital invested
Capital invested by funds: $4.37B → $4.62B (+$250M)
7% more repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 106
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
316
Holding in Top 10
2
Calls
$37.2M
Puts
$3.83M
Top Buyers
| 1 | +$73.6M | |
| 2 | +$40.1M | |
| 3 | +$37.4M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$36.8M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$33.9M |
Top Sellers
| 1 | -$38.1M | |
| 2 | -$22.6M | |
| 3 | -$19.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18.9M |
| 5 |
AIG
American International Group
New York
|
-$7.81M |